THERAPEUTICSMD, INC. — Earnings
Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR
Next earnings (estimated): Wed, April 1, 2026 — 30 days overdue (likely already filed but EDGAR cache cold). Anchored to latest quarter-end + 91 days. Analyst-confirmed dates land in a follow-up wave.
YoY = vs same quarter prior year (seasonality-adjusted)
Recent earnings · last 8 quarters
| Quarter end | Revenue | YoY | Net Income | YoY | Op. Margin |
|---|---|---|---|---|---|
| 2025-12-31 | $893K | ↑+33.9% | — | — | — |
| 2025-09-30 | $784K | ↑+43.3% | $152K | ↑+125.0% | -109.9% |
| 2025-06-30 | $952K | ↑+306.8% | $551K | ↑+150.6% | -73.0% |
| 2025-03-31 | $393K | ↑+25.6% | $-653K | ↑+11.0% | -221.6% |
| 2024-12-31 | $667K | ↓-48.7% | — | — | — |
| 2024-09-30 | $547K | ↑+1132.1% | $-609K | ↑+82.0% | -207.3% |
| 2024-06-30 | $234K | ↓-46.5% | $-1M | ↑+54.8% | -1191.9% |
| 2024-03-31 | $313K | ↓-24.8% | $-734K | ↑+79.6% | -364.9% |
Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.
Last earnings · FY2025 (Q4)
Revenue
$893K
↑+33.9% +$226K YoY
Net Income
$764K
↑+55.6% +$273K YoY
Earnings surprise · last 8 quarters
YoY % change · proxy for analyst surprise until estimates landEPS history · last 10 fiscal years
diluted, GAAP, annualNote: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.
Margin trends · 62 quarters
margin trajectory tells the operating-leverage storyGross Margin↑+19.8pts
38.6%
Operating Margin↑+97.4pts
-109.9%
Net Margin↑+130.7pts
19.4%
Go deeper
TXMD Sankey — flow of dollars
See how revenue waterfalls through every line item to net income for the latest reported quarter, with prior-period comparison.
Open SankeyTXMD Key Metrics — EPS, ROE, ROIC
10 CFA-grade fundamental ratios — EPS, BVPS, ROE, ROA, ROIC, Debt/Equity, Current Ratio. Compare across years.
Open Key Metrics